Orthobiologics Market Research Report Information By Product (Demineralized Bone Matrix and Bone Morphogenetic Protein), By Application (Osteoarthritis & Degenerative Arthritis and Spinal Fusion), By End User (Hospitals and Orthopedic Clinics), And By Region (Europe, North America, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

Chapter 6. Global Orthobiologics Market, by Product

6.1. Introduction

6.2. Demineralized bone matrix (DBM)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Bone morphogenetic protein (BPM)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Allograft

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Viscosupplementation products

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6. Synthetic bone substitutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.7. Others

Chapter 7. Global Orthobiologics Market, by Application

7.1. Introduction

7.2. Osteoarthritis & degenerative arthritis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Spinal fusion

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Fracture recovery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Soft tissue injuries

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Others

Chapter 8. Global Orthobiologics Market, by End User

8.1. Introduction

8.2. Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Orthopedic Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Others

Chapter 9. Global Orthobiologics Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Arthrex, Inc.

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Exactech, Inc.

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Globus Medical Inc

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Integra LifeSciences

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Medline Industries, Inc

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. NuVasive, Inc.

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Stryker Corporation

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Wright Medical Group N.V.

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Zimmer Biomet

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Orthobiologics Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Orthobiologics Market Synopsis, 2020–2027

Table 2. Global Orthobiologics Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3. Global Orthobiologics Market, by Region, 2020–2027 (USD Million)

Table 4. Global Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 5. Global Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 6. Global Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 7. North America: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 8. North America: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 9. North America: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 10. US: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 11. US: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 12. US: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 13. Canada: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 14. Canada: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 15. Canada: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 16. Latin America: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 17. Latin America: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 18. Latin America: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 19. Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 20. Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 21. Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 22. Western Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 23. Western Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 24. Western Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 25. Eastern Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 26. Eastern Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 27. Eastern Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 28. Asia-Pacific: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 29. Asia-Pacific: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 30. Asia-Pacific: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 31. Middle East & Africa: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 32. Middle East & Africa: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 33. Middle East & Africa: Orthobiologics Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Orthobiologics Market

Figure 3. Segmentation Market Dynamics for Global Orthobiologics Market

Figure 4. Global Orthobiologics Market Share, by Product, 2020

Figure 5. Global Orthobiologics Market Share, by Application, 2020

Figure 6. Global Orthobiologics Market Share, by End User, 2020

Figure 7. Global Orthobiologics Market Share, by Region, 2020

Figure 8. North America: Orthobiologics Market Share, by Country, 2020

Figure 9. Europe: Orthobiologics Market Share, by Country, 2020

Figure 10. Asia-Pacific: Orthobiologics Market Share, by Country, 2020

Figure 11. Middle East & Africa: Orthobiologics Market Share, by Country, 2020

Figure 12. Global Orthobiologics Market: Company Share Analysis, 2020 (%)

Figure 13. Arthrex, Inc.: Key Financials

Figure 14. Arthrex, Inc.: Segmental Revenue

Figure 15. Arthrex, Inc.: Geographical Revenue

Figure 16. Exactech, Inc.: Key Financials

Figure 17. Exactech, Inc.: Segmental Revenue

Figure 18. Exactech, Inc.: Geographical Revenue

Figure 19. Globus Medical Inc: Key Financials

Figure 20. Globus Medical Inc: Segmental Revenue

Figure 21. Globus Medical Inc: Geographical Revenue

Figure 22. Integra LifeSciences: Key Financials

Figure 23. Integra LifeSciences: Segmental Revenue

Figure 24. Integra LifeSciences: Geographical Revenue

Figure 25. Johnson & Johnson: Key Financials

Figure 26. Johnson & Johnson: Segmental Revenue

Figure 27. Johnson & Johnson: Geographical Revenue

Figure 28. Medline Industries, Inc: Key Financials

Figure 29. Medline Industries, Inc: Segmental Revenue

Figure 30. Medline Industries, Inc: Geographical Revenue

Figure 31. NuVasive, Inc.: Key Financials

Figure 32. NuVasive, Inc.: Segmental Revenue

Figure 33. NuVasive, Inc.: Geographical Revenue

Figure 34. Stryker Corporation: Key Financials

Figure 35. Stryker Corporation: Segmental Revenue

Figure 36. Stryker Corporation: Geographical Revenue

Figure 37. Wright Medical Group N.V.: Key Financials

Figure 38. Wright Medical Group N.V.: Segmental Revenue

Figure 39. Wright Medical Group N.V.: Geographical Revenue

Figure 40. Wright Medical Group N.V.: Key Financials

Figure 41. Wright Medical Group N.V.: Segmental Revenue

Figure 42. Wright Medical Group N.V.: Geographical Revenue